325 related articles for article (PubMed ID: 15980225)
1. D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board.
Nakamura S; Shibuya M; Nakashima H; Imagawa T; Uehara M; Tsubota K
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2379-87. PubMed ID: 15980225
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of D-beta-hydroxybutyrate on corneal epithelia in dry eye conditions through suppression of apoptosis.
Nakamura S; Shibuya M; Saito Y; Nakashima H; Saito F; Higuchi A; Tsubota K
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4682-8. PubMed ID: 14578386
[TBL] [Abstract][Full Text] [Related]
3. Topical apolipoprotein A-1 may have a beneficial effect on the corneal epithelium in a mouse model of dry eye: a pilot study.
Nyunt AK; Ishida Y; Yu Y; Shimada S
Eye Contact Lens; 2008 Sep; 34(5):287-92. PubMed ID: 18779669
[TBL] [Abstract][Full Text] [Related]
4. Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye.
Nakamura S; Shibuya M; Nakashima H; Hisamura R; Masuda N; Imagawa T; Uehara M; Tsubota K
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1552-8. PubMed ID: 17389484
[TBL] [Abstract][Full Text] [Related]
5. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
[TBL] [Abstract][Full Text] [Related]
6. Investigation of corneal effect of different types of artificial tears in a simulated dry eye condition using a novel porcine dry eye model (pDEM).
Choy EP; Cho P; Benzie IF; Choy CK
Cornea; 2006 Dec; 25(10):1200-4. PubMed ID: 17172898
[TBL] [Abstract][Full Text] [Related]
7. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis.
Chen W; Zhang X; Liu M; Zhang J; Ye Y; Lin Y; Luyckx J; Qu J
Exp Eye Res; 2009 Sep; 89(3):311-8. PubMed ID: 19345212
[TBL] [Abstract][Full Text] [Related]
8. Albumin rescues ocular epithelial cells from cell death in dry eye.
Higuchi A; Ueno R; Shimmura S; Suematsu M; Dogru M; Tsubota K
Curr Eye Res; 2007 Feb; 32(2):83-8. PubMed ID: 17364740
[TBL] [Abstract][Full Text] [Related]
9. Tear function and ocular surface findings in premature and term babies.
Dogru M; Karakaya H; Baykara M; Ozmen A; Koksal N; Goto E; Matsumoto Y; Kojima T; Shimazaki J; Tsubota K
Ophthalmology; 2004 May; 111(5):901-5. PubMed ID: 15121366
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of uridine on cornea in a rabbit dry eye model.
Oh JY; In YS; Kim MK; Ko JH; Lee HJ; Shin KC; Lee SM; Wee WR; Lee JH; Park M
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1102-9. PubMed ID: 17325152
[TBL] [Abstract][Full Text] [Related]
11. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
Fahnehjelm KT; Törnquist AL; Winiarski J
Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
[TBL] [Abstract][Full Text] [Related]
12. Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease.
Kawakita T; Uchino M; Fukagawa K; Yoshino K; Shimazaki S; Toda I; Tanaka M; Arai H; Sakatani K; Hata S; Okano T; Tsubota K
Sci Rep; 2016 Feb; 6():20855. PubMed ID: 26865350
[TBL] [Abstract][Full Text] [Related]
13. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
[TBL] [Abstract][Full Text] [Related]
14. [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].
Geerling G; Hartwig D
Ophthalmologe; 2002 Dec; 99(12):949-59. PubMed ID: 12478384
[TBL] [Abstract][Full Text] [Related]
15. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of the effectiveness of a dexpanthenol containing artificial tears solution (Siccaprotect) in treatment of dry eyes].
Göbbels M; Gross D
Klin Monbl Augenheilkd; 1996; 209(2-3):84-8. PubMed ID: 8992089
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
18. An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye.
Jain P; Li R; Lama T; Saragovi HU; Cumberlidge G; Meerovitch K
Exp Eye Res; 2011 Oct; 93(4):503-12. PubMed ID: 21726552
[TBL] [Abstract][Full Text] [Related]
19. Serial measurements of higher-order aberrations after blinking in patients with dry eye.
Koh S; Maeda N; Hirohara Y; Mihashi T; Bessho K; Hori Y; Inoue T; Watanabe H; Fujikado T; Tano Y
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):133-8. PubMed ID: 18172085
[TBL] [Abstract][Full Text] [Related]
20. Keratoconjunctivitis sicca modifies epithelial stem cell proliferation kinetics in conjunctiva.
Chen W; Zhao K; Li X; Yoshitomi T
Cornea; 2007 Oct; 26(9):1101-6. PubMed ID: 17893543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
